Administrative information
Title {1} |
Complex Physical Therapy employing self-adjusting garment (ReadyWrap®) in breast cancer-related lymphedema cases in Brazilian women: A protocol for a randomized clinical trial
|
Trial registration {2a and 2b}. | NCT04934098 [Clinical trials phase 1] (registered on June 22, 2021) NCT04881604 [Clinical trials phase 2] (registered on May 11, 2021) CEP/INCA 4611711 [local ethics committee registration approval number] |
Protocol version {3} | Version 2 of March 25, 2021 |
Funding {4} | An agreement was signed among the management of the National Cancer Institute, the institute’s ethics committee, and VENOSAN BRASIL LTDA, a company. The institute provided financial support to students (JMPS, RDDA, and FCSS) enrolled in teaching programs who conducted the research. Furthermore, VENOSAN BRASIL LTDA provided the compressive devices, which were offered free of charge to the research participants. |
Author details {5a} | 1 Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil 2 physiotherapist and researcher at Institute Celulare, Rio de Janeiro, RJ, Brazil |
Name and contact information for the trial sponsor {5b} | Anke Bergmann—Brazilian National Cancer Institute (INCA). Address: Rua André Cavalcanti, 37—Centro, Rio de Janeiro—RJ, ZIPCODE 20231–050. Brazil. Phone: + 55 21 3207–6551. E-mail: abergmann@inca.gov.br |
Role of sponsor {5c} | Despite the private company providing compression devices free of charge to research participants and the institute offering scholarships to teaching program students, it is important to note that this is an investigator-initiated clinical trial. The funders had no involvement in the study’s design and will not be involved in its execution, data collection, data analysis, data interpretation, or the decision to submit results. Additionally, there was no financial support for the writing of the manuscript. |
Introduction
Background and rationale {6a}
Objectives {7}
Trial design {8}
Methods: participants, interventions, and outcomes
Study setting {9}
Eligibility criteria {10}
Treatment phase | Inclusion criteria |
---|---|
Phase 1: Volume reduction | Women with volume changes ≥ 10% or perimetry differences ≥ 3 cm in at least one point compared to the contralateral limb, with an indication of compressive bandaging according to the institutional routine [12] |
Phase 2: Volume maintenance | Women with stabilized lymphedema with an indication of compressive mesh according to the institutional routine [12] |